Sign in
SPRC Stock Price, Chart, Stats & News
SciSparc Ltd.
Save
SciSparc Ltd. (SPRC) does not currently pay a dividend.
319,271
Market cap
–
Current P/E
–
Forward P/E
SPRC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 21.90% |
Operating margin | -2156.85% |
Pretax margin | -1426.54% |
Net margin | -1312.84% |
Effective tax rate | 0.14% |
ROA | -236.82% |
ROE | -330.17% |
D/E | -3.14x |
Interest coverage ratio | -18.38x |
SPRC valuation
P/E | – |
P/S | 0.24x |
P/B | -0.29x |
P/CF | -0.05x |
P/FCF | -0.05x |
P/OCF | -0.05x |
PEG | -0.00x |
EV multiple | 0.06x |
About
SciSparc Ltd. is a pharmaceutical company in the clinical development phase, specializing in creating medications derived from cannabinoid molecules. Their therapeutic pipeline encompasses several key drug candidates: SCI-110, which is being investigated for the treatment of Tourette syndrome, obstructive sleep apnea, and agitation associated with Alzheimer's disease; SCI-160, designed to address pain; and SCI-210, targeting autism spectrum disorder and epilepsy. The company has formed strategic alliances to further its goals.
Similar securities
Based on sector and market capitalization
Report issue